代替的転写イニシアチブは,がんにおける新しいALKイソフォームの発現につながる
Thomas Wiesner1,2, William Lee3,4, Anna C Obenauf5
1Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York 10065, USA.
Nature
|October 8, 2015
まとめ
新しいアナプラスティックリンパ腫キナーゼ (ALK) 異形,ALK ((ATI) は,遺伝的変化ではなく,代替転写開始によるメラノーマの11%で活性化されます. この発見は 癌の治療に 新たな治療目標をもたらします
科学分野:
- 腫瘍学
- 分子生物学
- 遺伝学
背景:
- 遺伝的異常を超えた腫瘍遺伝子の活性化のメカニズムはよく理解されていません.
- アナプラスティックリンパ腫キナーゼ (ALK) は既知の腫瘍遺伝子ですが,その活性化経路は完全に解明されていません.
研究 の 目的:
- 癌における腫瘍遺伝子の活性化の新しいメカニズムを特定し,特徴づけること.
- メラノーマや他の癌における新発見のALKイソフォームの役割を調査する.
主な方法:
- 新しいALK同型を特定するためのトランスクリプトミックの分析.
- 活性転写マーク (H3K4me3,RNAポリメラーゼII) を評価するためのクロマチンの免疫流出.
- マウスにおける細胞増殖試験と体内の腫瘍形成モデル.
主要な成果:
- 新しいALK同型 (ALK(ATI) が,イントロン19の代替転写開始部位から発現した.
- ALK ((ATI)) は,約11%のメラノーマで, sporadically 他の癌で発見されましたが,正常な組織ではありません.
- ALKの発現はALKの位置における遺伝的異常とは無関係であり,腫瘍発生信号伝達,細胞増殖,腫瘍発生を促した.
結論:
- 癌における腫瘍遺伝子の活性化のための新しいメカニズムを表しています.
- ALKの活性がALK阻害剤によって抑制される可能性があるため,ALK (AT) は潜在的な治療標的である.
- ALK ((ATI)) を発現する腫瘍を有する患者に有益である.
関連する概念動画
RNA Splicing
61.4K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
61.4K
Alternative RNA Splicing
26.6K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
26.6K
Alternative RNA Splicing
5.5K
5.5K
Cancer-Critical Genes I: Proto-oncogenes
12.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
12.0K
Cancer-Critical Genes I: Proto-oncogenes
6.2K
6.2K
Non-LTR Retrotransposons
14.0K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
14.0K


